Post-transplant acute limbic encephalitis: Difference between revisions
From IDWiki
(→) |
No edit summary |
||
Line 2: | Line 2: | ||
== Background == |
== Background == |
||
− | * Caused by [[HHV-6B]] |
+ | * Caused by [[HHV-6B]][[CiteRef::ongrádi2016ro]] |
== Clinical Presentation == |
== Clinical Presentation == |
||
Line 14: | Line 14: | ||
* Treat any possible concomitant risk factors such as hyponytremia |
* Treat any possible concomitant risk factors such as hyponytremia |
||
* Antivirals: [[Is treated by::acyclovir]], [[Is treated by::ganciclovir]], or [[Is treated by::foscarnet]] for 10 days to 4 weeks |
* Antivirals: [[Is treated by::acyclovir]], [[Is treated by::ganciclovir]], or [[Is treated by::foscarnet]] for 10 days to 4 weeks |
||
+ | |||
+ | == Further Reading == |
||
+ | * Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. ''Neurology''. 2007;69(2):156-165. DOI: [https://doi.org/10.1212/01.wnl.0000265591.10200.d7 10.1212/01.wnl.0000265591.10200.d7] |
||
[[Category:Immunocompromised hosts]] |
[[Category:Immunocompromised hosts]] |
Revision as of 20:06, 10 February 2020
- Limbic encephalitis syndrome following hematopoietic stem cell transplantation
Background
Clinical Presentation
- Onset 2 weeks to 2 months after transplant
- Presents with confusion, amnesia, hallucinations
- Can cause seizures
- Hyponatremia is common
Management
- Treat seizures with antiepileptic medications
- Treat any possible concomitant risk factors such as hyponytremia
- Antivirals: acyclovir, ganciclovir, or foscarnet for 10 days to 4 weeks
Further Reading
- Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69(2):156-165. DOI: 10.1212/01.wnl.0000265591.10200.d7
References
- ^ Joseph Ongrádi, Dharam V. Ablashi, Tetsushi Yoshikawa, Balázs Stercz, Masao Ogata. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals. Journal of NeuroVirology. 2016;23(1):1-19. doi:10.1007/s13365-016-0473-0.